Cardiac tamponade resident survival guide: Difference between revisions
Line 29: | Line 29: | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | E01 | | | | | | | | |E01= '''Echocardiography:'''<br> ❑ Effusion types B- D according to Horowitz classification: <br> ♦ Type A: No effusion <br> ♦ Type B: Separation of epicardium and pericardium (3–16 ml)<br> ♦ Type C 1: Systolic and diastolic separation of epicardium and pericardium (small effusion >16 ml)<br> ♦ Type C 2: Systolic and diastolic separation of epicardium and pericardium with attenuated pericardial motion<br> ♦ Type D: Pronounced separation of epicardium and pericardium with large echo- free space<br> ♦ Type E: Pericardial thickening (>4 mm)}} | {{familytree | | | | | | | E01 | | | | | | | | |E01= <div style="float: left; text-align: left; line-height: 150% ">'''Echocardiography:'''<br> ❑ Effusion types B- D according to Horowitz classification: <br> ♦ Type A: No effusion <br> ♦ Type B: Separation of epicardium and pericardium (3–16 ml)<br> ♦ Type C 1: Systolic and diastolic separation of epicardium and pericardium (small effusion >16 ml)<br> ♦ Type C 2: Systolic and diastolic separation of epicardium and pericardium with attenuated pericardial motion<br> ♦ Type D: Pronounced separation of epicardium and pericardium with large echo- free space<br> ♦ Type E: Pericardial thickening (>4 mm)</div>}} | ||
{{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | }} | {{familytree | | | |,|-|-|-|^|-|-|-|.| | | | | }} | ||
{{familytree | | | F01 | | | | | | F02 | | | | |F01='''Evidence of pericardial effusion''' |F02=<div style="float: left; text-align: left; line-height: 150% ">'''Order lab tests:''' <br> ❑ Inflammation markers: <br>♦[[ESR]] <br> ♦[[CRP]] <br> ♦[[LDH]] <br> ❑ Markers of myocardial lesion:<br> ♦[[Troponin I]] <br> ♦[[CK MB]]</div> }} | {{familytree | | | F01 | | | | | | F02 | | | | |F01='''Evidence of pericardial effusion''' |F02=<div style="float: left; text-align: left; line-height: 150% ">'''Order lab tests:''' <br> ❑ Inflammation markers: <br>♦[[ESR]] <br> ♦[[CRP]] <br> ♦[[LDH]] <br> ❑ Markers of myocardial lesion:<br> ♦[[Troponin I]] <br> ♦[[CK MB]]</div> }} |
Revision as of 19:28, 17 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Definitions
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Shown below is an algorithm showing acute pericarditis management.[1]
Characterize the symptoms: ❑ Prodrome: | |||||||||||||||||||||||||||||||||
Auscultation: ❑ Pericardial rub | |||||||||||||||||||||||||||||||||
Perform ECG: ❑ Convexly elevated J-ST segment | |||||||||||||||||||||||||||||||||
Echocardiography: ❑ Effusion types B- D according to Horowitz classification: ♦ Type A: No effusion ♦ Type B: Separation of epicardium and pericardium (3–16 ml) ♦ Type C 1: Systolic and diastolic separation of epicardium and pericardium (small effusion >16 ml) ♦ Type C 2: Systolic and diastolic separation of epicardium and pericardium with attenuated pericardial motion ♦ Type D: Pronounced separation of epicardium and pericardium with large echo- free space ♦ Type E: Pericardial thickening (>4 mm) | |||||||||||||||||||||||||||||||||
Evidence of pericardial effusion | Order lab tests: ❑ Inflammation markers: ♦ESR ♦CRP ♦LDH ❑ Markers of myocardial lesion: ♦Troponin I ♦CK MB | ||||||||||||||||||||||||||||||||
Horowitz Classification
Dos
Don'ts
References
- ↑ Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y; et al. (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". Eur Heart J. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.